Cardinal Health stock trades at EUR 212.40, market value USD 55.6 billion
Published on 10/08/2026 at 19:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Cardinal Health stock was at EUR 212.40 at Lang & Schwarz on October 8, 2026, up 2.44 percent versus EUR 207.35.
- The USD 55.6 billion market value and P/E of 32.88 frame the latest valuation.
- First-quarter fiscal 2027 results are scheduled for November 5, 2026.
- McKesson and Cencora posted same-day gains of 1.92 percent and 0.69 percent, respectively.
Cardinal Health (ISIN US14149Y1082) was at EUR 212.40 at Lang & Schwarz on October 8, 2026 at 7:44 p.m. CEST, up 2.44 percent versus the prior close of EUR 207.35. The after-hours quote puts the stock near the upper half of its recent trading range while the company prepares its next results release.
Price sits at EUR 212.40
The primary-market quote was USD 237.44 on the NYSE at 1:54 p.m. EDT on October 8, 2026. The session range was USD 231.25 to USD 238.80, while trading volume stood at 421,155 shares against an average volume of 1,912,345 shares.
Cardinal Health's USD 237.44 primary-market price was USD 20.86 below the 52-week high of USD 258.30, a gap of 8.08 percent. It was USD 85.57 above the 52-week low of USD 151.87, placing the share price 56.34 percent above that floor.
Market value reaches USD 55.6 billion
Cardinal Health carried a market capitalization of USD 55.6 billion and a P/E ratio of 32.88 on October 8, 2026. MarketBeat reported a quarterly dividend yield of 0.90 percent on October 5, 2026.
StockAnalysis identifies Cardinal Health as a healthcare services and products company listed on the NYSE under CAH. Its fiscal year runs from July through June, making the next reporting date particularly relevant for the market's assessment of the new fiscal year.
Comparison with peers
Cardinal Health: plus 2.44 percent, P/E 32.88, market capitalization USD 55.6 billion
McKesson (NYSE, USD): plus 1.92 percent, P/E 24.86, market capitalization USD 108.6 billion
Cencora (NYSE, USD): plus 0.69 percent, P/E 23.73, market capitalization USD 62.2 billion
November 5 is the next date
According to MarketBeat on October 5, 2026, Cardinal Health plans to report first-quarter fiscal 2027 results on November 5, 2026. That release will provide the next dated test for revenue, adjusted earnings per share and the company's full-year outlook.
At Lang & Schwarz, Cardinal Health was at EUR 212.40 after hours on October 8, 2026 at 7:44 p.m. CEST, plus 2.44 percent versus the prior close of EUR 207.35. The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.
Cardinal Health market snapshot
- Company: Cardinal Health, Inc.
- ISIN: US14149Y1082
- Ticker: CAH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 8, 2026, 7:44 p.m. CEST): EUR 212.40
- Change versus prior close: plus 2.44 percent
- Prior close Lang & Schwarz (October 7, 2026): EUR 207.35
- Market capitalization: USD 55.6 billion (as of October 8, 2026)
- 52-week range: USD 151.87-258.30 (as of October 8, 2026)
- Sector / Industry: Health Care / Medical Distribution
- Index membership: S&P 500
- Next earnings date: November 5, 2026
Market context: Market report S&P 500.
